Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Homozygous Familial Hypercholesterolemia

NCT04659863 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Familial Hypercholesterolemia - Homozygous

Interventions

DRUG: Inclisiran
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals